Incidence of, and survival after, CNS tumors in children

Research output: Contribution to journalArticle

Abstract

The present paper discusses the incidence and survival rates of pediatric patients with CNS tumor in Italy and Europe. Frequency and prognosis data according to tumor type were taken from the "International incidence of childhood cancer, Vol. II" and EUROCARE study. Registers of tumors are the main source of data. The yearly incidence of malignant CNS tumors in Europe varies from 40 (Sweden) to 20 (Slovenia) cases per million and is slightly higher in males. About 50% of CNS tumors are astrocytomas, with incidence rates ranging between 22 and 8 in Europe. Some studies report an increase in incidence but this may partly be due to an improved diagnostic ability. Survival at 5 years from diagnosis is 78% for astrocytoma, 50% for PNET/medulloblastoma and 55% for ependymomas. Prognosis is fatal for children aged less than 1 year and slightly more unfavorable for males. Children from Nordic countries show longer survival. Between 1983-1994 the mean reduction of death risk decreased by about 3% yearly. A higher incidence and improved survival of CNS tumor survivors require appropriate treatment and rehabilitation planning. The variable rates of survival in Europe suggest a possible improvement in countries where survival is lower.

Original languageEnglish
Pages (from-to)9-16
Number of pages8
JournalSAGGI - Child Development and Disabilities
Volume30
Issue number2
Publication statusPublished - 2004

Fingerprint

Survival
Incidence
Neoplasms
Astrocytoma
Survival Rate
Scandinavian and Nordic Countries
Slovenia
Primitive Neuroectodermal Tumors
Ependymoma
Medulloblastoma
Aptitude
Information Storage and Retrieval
Risk Reduction Behavior
Sweden
Italy
Survivors
Rehabilitation
Pediatrics
Therapeutics

Keywords

  • Cancer registry
  • Childhood brain tumors
  • Epidemiology
  • Incidence
  • Survival

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Rehabilitation
  • Neuropsychology and Physiological Psychology

Cite this

Incidence of, and survival after, CNS tumors in children. / Gatta, G.

In: SAGGI - Child Development and Disabilities, Vol. 30, No. 2, 2004, p. 9-16.

Research output: Contribution to journalArticle

@article{e6148b67af44454a835ae91825680425,
title = "Incidence of, and survival after, CNS tumors in children",
abstract = "The present paper discusses the incidence and survival rates of pediatric patients with CNS tumor in Italy and Europe. Frequency and prognosis data according to tumor type were taken from the {"}International incidence of childhood cancer, Vol. II{"} and EUROCARE study. Registers of tumors are the main source of data. The yearly incidence of malignant CNS tumors in Europe varies from 40 (Sweden) to 20 (Slovenia) cases per million and is slightly higher in males. About 50{\%} of CNS tumors are astrocytomas, with incidence rates ranging between 22 and 8 in Europe. Some studies report an increase in incidence but this may partly be due to an improved diagnostic ability. Survival at 5 years from diagnosis is 78{\%} for astrocytoma, 50{\%} for PNET/medulloblastoma and 55{\%} for ependymomas. Prognosis is fatal for children aged less than 1 year and slightly more unfavorable for males. Children from Nordic countries show longer survival. Between 1983-1994 the mean reduction of death risk decreased by about 3{\%} yearly. A higher incidence and improved survival of CNS tumor survivors require appropriate treatment and rehabilitation planning. The variable rates of survival in Europe suggest a possible improvement in countries where survival is lower.",
keywords = "Cancer registry, Childhood brain tumors, Epidemiology, Incidence, Survival",
author = "G. Gatta",
year = "2004",
language = "English",
volume = "30",
pages = "9--16",
journal = "SAGGI - Child Development and Disabilities",
issn = "0390-5179",
publisher = "Associazione La Nostra Famiglia",
number = "2",

}

TY - JOUR

T1 - Incidence of, and survival after, CNS tumors in children

AU - Gatta, G.

PY - 2004

Y1 - 2004

N2 - The present paper discusses the incidence and survival rates of pediatric patients with CNS tumor in Italy and Europe. Frequency and prognosis data according to tumor type were taken from the "International incidence of childhood cancer, Vol. II" and EUROCARE study. Registers of tumors are the main source of data. The yearly incidence of malignant CNS tumors in Europe varies from 40 (Sweden) to 20 (Slovenia) cases per million and is slightly higher in males. About 50% of CNS tumors are astrocytomas, with incidence rates ranging between 22 and 8 in Europe. Some studies report an increase in incidence but this may partly be due to an improved diagnostic ability. Survival at 5 years from diagnosis is 78% for astrocytoma, 50% for PNET/medulloblastoma and 55% for ependymomas. Prognosis is fatal for children aged less than 1 year and slightly more unfavorable for males. Children from Nordic countries show longer survival. Between 1983-1994 the mean reduction of death risk decreased by about 3% yearly. A higher incidence and improved survival of CNS tumor survivors require appropriate treatment and rehabilitation planning. The variable rates of survival in Europe suggest a possible improvement in countries where survival is lower.

AB - The present paper discusses the incidence and survival rates of pediatric patients with CNS tumor in Italy and Europe. Frequency and prognosis data according to tumor type were taken from the "International incidence of childhood cancer, Vol. II" and EUROCARE study. Registers of tumors are the main source of data. The yearly incidence of malignant CNS tumors in Europe varies from 40 (Sweden) to 20 (Slovenia) cases per million and is slightly higher in males. About 50% of CNS tumors are astrocytomas, with incidence rates ranging between 22 and 8 in Europe. Some studies report an increase in incidence but this may partly be due to an improved diagnostic ability. Survival at 5 years from diagnosis is 78% for astrocytoma, 50% for PNET/medulloblastoma and 55% for ependymomas. Prognosis is fatal for children aged less than 1 year and slightly more unfavorable for males. Children from Nordic countries show longer survival. Between 1983-1994 the mean reduction of death risk decreased by about 3% yearly. A higher incidence and improved survival of CNS tumor survivors require appropriate treatment and rehabilitation planning. The variable rates of survival in Europe suggest a possible improvement in countries where survival is lower.

KW - Cancer registry

KW - Childhood brain tumors

KW - Epidemiology

KW - Incidence

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=11144225790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144225790&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:11144225790

VL - 30

SP - 9

EP - 16

JO - SAGGI - Child Development and Disabilities

JF - SAGGI - Child Development and Disabilities

SN - 0390-5179

IS - 2

ER -